Category
22 stories · page 1 of 2
Skin
A source-led audit of Symrise’s new Lautier 1795 site, the EU’s expanded fragrance-allergen labels, and why natural does not automatically mean safer.
Skin
Clariant says Genadvance Revive uses styling heat as part of a hair-repair mechanism. We examine what its supplier tests measured, what independent hair-fibre studies establish, and why heat activation does not make high-temperature styling harmless.
Skin
Seppic’s Sepilife NEOS launch turns squalane into a formulation story. We separate verified launch facts from supplier performance claims, explain what ISO 16128 and EU microplastics rules do and do not establish, and list the evidence still missing.
Skin
Clariant’s new KanuFresh ingredient arrives with striking sweat, odour and irritation figures. LCY separates the verified launch facts from unpublished supplier evidence, regulation and real-world safety.
Trends
PDRN, exosomes and peptides may share retail momentum, but they are not one efficacy class; identity, route, dose and finished-product evidence remain decisive.
Trends
Biology and biomarkers can guide research, but extending “skin longevity” is not yet a standardized clinical outcome or a blanket cosmetic claim.
Trends
Temperature, humidity and pollution can influence skin measurements, but heterogeneous environmental evidence does not prove that a “climate-adaptive” cosmetic works.
Trends
A European expert consensus can organize research questions, but it is not product-outcome evidence or proof of a global market trend.
Trends
A survey-led trend signal on post-weight-loss skin concerns, separated from clinical evidence for skin change and from claims that any aesthetic treatment is effective.
Skin
Three primary company disclosures point to very different kinds of beauty momentum in 2026. LCY compares the periods, metrics and category signals without turning unlike numbers into a false ranking.
Skin
Shiseido’s 21 August 2026 announcement of a new Elixir high-moisture lotion is a useful product-intelligence signal, but it is not independent proof of superior skin outcomes. LifeCareYou separates what the company has documented about the launch from what still needs finished-product, comparative and post-market evidence. The timely signal is the claim language: the release defines “mask-level” as moisturizing performance equivalent to an Elixir sheet mask, then separately states a...
Trends
What subscribers receive from The LCY Edit, how sources and commercial relationships are labelled, and why unverified offers are never presented as member benefits.
